Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07465172) titled 'GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast Cancer' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
Primary Sponsor: Breast Cancer Trials, Australia and New Zealand
Condition:
Breast Cancer
Intervention:
Other: Blood collection for GDF-15
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 2026
Target Sample Size: 150
Countries of Recruitment:
United States
Australia
Japan
Australia
Japan
United States
To know more, ...